Source: Annual Congress 2003 - Cystic fibrosis: modern methods of monitoring the disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Cardinale, A. Manca, L. Mappa, R. Tesse, R. Cavallone, M. S. Loffredo, A. Dellino, I. Chinellato, R. Rubino, G. Iacoviello, N. Rigillo, L. Armenio, E. Costantino (Bari, Italy). Effects on exhaled nitric oxide levels and lung function of ultrasonically nebulized hypertonic solution in cystic fibrosis. Eur Respir J 2003; 22: Suppl. 45, 1546

Member's Comments

No comment yet.

Related content which might interest you: Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Airway acidification and exhaled nitric oxide in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003 Reduced exhaled nitric oxide in infants with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Exhaled nitric oxide is not reduced in infants with cystic fibrosis Source: Eur Respir J 2006; 27: 350-354 Year: 2006 Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments Source: Eur Respir J 2009; 34: 117-124 Year: 2009 Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Orally and nasally exhaled nitric oxide and nitrite in asthmatic and cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003 Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients Source: Eur Respir J 2001; 17: 1267-1270 Year: 2001 The impact of hypertonic saline inhalation on nasal nitric oxide levels and mucociliary clearance Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease Year: 2013 Exhaled nitric oxide, methacoline and hypertonic saline inhalation in normal subjects Source: Eur Respir J 2001; 18: Suppl. 33, 164s Year: 2001 Inhaled nitric oxide increases alveolar liquid clearance in rabbit with endotoxin induced lung injury Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004 Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis Source: Eur Respir J 2001; 17: 1201-1207 Year: 2001 Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018 Year: 2019 Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002 The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 181s Year: 2001 Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis Source: Annual Congress 2007 - Noninvasive evaluation of airway diseases Year: 2007 Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings Source: Eur Respir J 2004; 24: Suppl. 48, 157s Year: 2004 Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity Year: 2016 Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Reduced bronchial nitric oxide flux but unchanged alveolar nitric oxide concentration after exposure to hyperbaric hyperoxia Source: Annual Congress 2010 - New diagnostic approaches in respiratory function Year: 2010